• LAST PRICE
    ---
  • TODAY'S CHANGE (%)
    Trending Down--- (---)
  • Bid / Lots
    0.0000/ 0
  • Ask / Lots
    0.0000/ 0
  • Open / Previous Close
    --- / ---
  • Day Range
    ---
  • 52 Week Range
    ---
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCPLFY
Cipla Ltd
10.6B
---
---
United StatesCRMD
CorMedix Inc
117.4M
-3.5x
---
United StatesASMB
Assembly Biosciences Inc
80.4M
-0.6x
---
United StatesNHWK
NightHawk Biosciences Inc
44.4M
-1.1x
---
United StatesALID
Allied Corp
55.2M
---
---
United StatesNOVN
Novan Inc
36.4M
-1.0x
---
As of 2022-10-01

Company Information

Cipla Limited is an India-based company that is primarily engaged in the business of pharmaceuticals. The Company’s segments include Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. Its product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 46 manufacturing sites.

Contact Information

Headquarters
Mumbai CentralMUMBAI, India 400013
Phone
222-482-6000
Fax
222-482-6120

Executives

Non-Executive Chairman of the Board
Yusuf Hamied
Global Chief Executive Officer, Managing Director, Executive Director
Umang Vohra
Executive Vice Chairman of the Board
Samina Hamied
Non-Executive Vice Chairman of the Board
M. Hamied
Global Chief Financial Officer
Ashish Adukia

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.6B
Revenue (TTM)
$284.6M
Shares Outstanding
807.0M
Cipla Ltd does not pay a dividend.
Beta
---
EPS
$0.04
Book Value
$0.63
P/E Ratio
---
Price/Sales (TTM)
37.2
Price/Cash Flow (TTM)
185.9x
Operating Margin
22.16%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.